Trend Results : Harold C. Simmons Comprehensive Cancer


Blog Post Results (1-16 of 16)

FILTER RESULTS

Good-guy bacteria may help cancer immunotherapies do their job

(UT Southwestern Medical Center) Individuals with certain types of bacteria in their gut may be more likely to respond well to cancer immunotherapy, researchers at the Harold C. Simmons Comprehensive Cancer Center found in a study of patients with metastatic melanoma.

Good-Guy Bacteria May Help Cancer Immunotherapies Do Their Job

Individuals with certain types of bacteria in their gut may be more likely to respond well to cancer immunotherapy, researchers at the Harold C. Simmons Comprehensive Cancer Center found in a study of patients with metastatic melano...

Genetic targets to chemo-resistant breast cancer identified

(UT Southwestern Medical Center) Research led by Dr. Carlos Arteaga, Director of the Harold C. Simmons Comprehensive Cancer Center, has identified potential targets for treatment of triple negative breast cancer, the most aggressive form of breast cancer.

Breast Cancer Specialist, Dr. Carlos L. Arteaga, to Head UT Southwestern's Simmons Comprehensive Cancer Center

Dr. Carlos L. Arteaga, internationally recognized for his work in laboratory-based translational research and advancing the care of breast cancer patients, has been selected as Director of the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern, after an extensive nationwide search.

Lung Cancer May Go Undetected in Kidney Cancer Patients

Could lung cancer be hiding in kidney cancer patients? Researchers with the Harold C. Simmons Comprehensive Cancer Center's Kidney Cancer Program studied patients with metastatic kidney cancer to the lungs and found that 3.5 percent of the group had a primary lung cancer tumor that had gone undiagnosed. This distinction can affect treatment choices and rates of survival.

Lung cancer may go undetected in kidney cancer patients

(UT Southwestern Medical Center) Could lung cancer be hiding in kidney cancer patients? Researchers with the Harold C. Simmons Comprehensive Cancer Center's Kidney Cancer Program studied patients with metastatic kidney cancer to the lungs and found that 3.5 percent of the group had a primary lung cancer tumor that had gone undiagnosed. Show More Summary

Researchers discover BRCA1 gene is key for blood forming stem cells

10 months agoHealth : EurekAlert: Health

(UT Southwestern Medical Center) Researchers at from the Harold C. Simmons Comprehensive Cancer Center have found that the BRCA1 gene is required for the survival of blood forming stem cells, which could explain why patients with BRCA1 mutations do not have an elevated risk for leukemia. The stem cells die before they have an opportunity to transform into a blood cancer.

Researchers Discover BRCA1 Gene Is Key for Blood Forming Stem Cells

Researchers at from the Harold C. Simmons Comprehensive Cancer Center have found that the BRCA1 gene is required for the survival of blood forming stem cells, which could explain why patients with BRCA1 mutations do not have an elevated risk for leukemia. The stem cells die before they have an opportunity to transform into a blood cancer.

Drug-loaded synthetic nanoparticles can distinguish lung cancer cells from healthy cells

Researchers with the Harold C. Simmons Comprehensive Cancer Center successfully developed a synthetic polymer that can transport a drug into lung cancer cells without going inside of normal lung cells.

New HIF-2 Kidney Cancer Therapy More Effective Than Current Treatment, Study Shows

A new class of drugs called HIF-2 inhibitors is more effective and better tolerated than the standard of care drug sunitinib in treating kidney cancer, researchers with the Kidney Cancer Program at Harold C. Simmons Comprehensive Cancer Center have found.

UT Southwestern's Simmons Cancer Center Recognized for Comprehensive Care

UT Southwestern Medical Center has been recognized by Becker's Hospital Review for its comprehensive cancer services and care, provided through the Harold C. Simmons Comprehensive Cancer Center.

UT Southwestern Targets Rising Rates of Kidney Cancer with Four-Pronged Attack Funded by National Cancer Institute

Bolstering its progress in addressing the rising threat of kidney cancer, the Kidney Cancer Program at UT Southwestern Medical Center's Harold C. Simmons Comprehensive Cancer Center has received $11 million in funding from the National Cancer Institute (NCI). Kidney cancer currently has no method of early detection and is particularly challenging to treat.

UT Southwestern's Simmons Cancer Center Director, Associate Dean named Chief Scientific Officer for CPRIT

Dr. James K.V. Willson, Associate Dean of Oncology Programs, and Professor and Director of the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern Medical Center, has been named Chief Scientific Officer of the Cancer Prevention and Research Institute of Texas (CPRIT), effective March 1.

NIH National Cancer Institute Awards Top-Tier Comprehensive Status to UT Southwestern's Harold C. Simmons Comprehensive Cancer Center

The National Cancer Institute (NCI) has awarded UT Southwestern Medical Center's Harold C. Simmons Comprehensive Cancer Center its highest designation, making it one of only 45 cancer centers nationally to receive this distinction over the past 44 years.

Mobile Cancer Survivor Clinic Brings UTSW Expertise to Doorstep of Underserved Cancer Survivors

UT Southwestern's Moncrief Cancer Institute and Harold C. Simmons Comprehensive Cancer Center debuted the Mobile Cancer Survivor Clinic ? a custom, fully equipped 18-wheeler that can deliver follow-up and screening services to cancer survivors.

UT Southwestern's Cancer Center Earns National Cancer Institute Designation

The Harold C. Simmons Comprehensive Cancer Center at UT Southwestern Medical Center has attained National Cancer Institute (NCI) designation, an elite distinction held by only 65 other cancer centers nationwide.

Copyright © 2015 Regator, LLC